NCT04212702 ESR1 Mutations in Asian ER+ Metastatic Breast Cancer on Hormonal Therapy-based Treatments Status UNKNOWN Phase N/A
NCT04188548 A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04176354 Real-world Treatment Patterns and Effectiveness of Palbociclib and AI Therapy Status COMPLETED Phase N/A
NCT04175171 Clinical Trial of Comparative Study of GB221 Pharmacokinetics Status COMPLETED Phase PHASE1
NCT04173897 Living Better With Advanced Breast Cancer: Feasibility Evaluation of an Online Supportive Intervention. Status COMPLETED Phase NA
NCT04170634 Tumoral Bone Strength Assessment by Numerical Simulation Using Quantitative CT : the MEKANOS Study Status RECRUITING Phase N/A
NCT04165993 Study of KN026 Monotherapy or Combination Therapy in Patients With Metastatic Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04163159 Genetic Markers of Circulating Tumor DNA for Monitoring Breast Cancer Patients in Costa Rica Status UNKNOWN Phase N/A
NCT04159818 Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients Status RECRUITING Phase PHASE2
NCT04143906 Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast Cancer Status UNKNOWN Phase PHASE2
NCT04143282 Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment Status COMPLETED Phase PHASE2
NCT04140526 Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04134884 Study of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT04129346 Technology-Supported Physical Activity Intervention for Metastatic Breast Cancer Survivors: Fit2ThriveMB Status COMPLETED Phase NA
NCT04120298 Effects of Exercise in Patients With Metastatic Breast Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT04115306 Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT04103853 Safety, Tolerability, and Pharmacokinetics of Proxalutamide Therapy in Women With Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT04095390 A Phase Ⅱ Trial of Pyrotinib Combination With CDK4/6 Inhibitor SHR6390 in Patients Prior Trastuzumab-treated Advanced HER2-Positive Breast Cancer Status UNKNOWN Phase PHASE2
NCT04092816 Fathers and Mothers Invested in Lives of Their Youth (FAMILY) Study: A Pilot Intervention Status TERMINATED Phase NA
NCT04088110 Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer Status UNKNOWN Phase PHASE2